Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Aim Immunotech, Amerimmune, Ampio, Astrazeneca, Brickell, Cytodyn, Galecto, Hightide, Histogen, Immutep, Innovent, Kaken, Noveome, Partner, Redhill, Scancell, Shenzhen Kangtai Biological Products, Sorrento, Sosei, Telix, Theravance.